Top Banner
Control the spread of VRE so it doesn’t control you
4

Control the spread of VRE so it doesn’t control you

May 31, 2022

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Control the spread of VRE so it doesn’t control you

Control the spread of VRE so it doesn’t control you

Page 2: Control the spread of VRE so it doesn’t control you

2

Brilliance™ VRE Agar is a chromogenic screening plate for the detection of Vancomycin Resistant Enterococci (VRE). The medium provides presumptive identification of Enterococcus faecium and Enterococcus faecalis, direct from clinical samples.

Saves Time• Presumptive identification of vancomycin resistant

E. faecium and E. faecalis in 24 hours, direct from sample

Convenient & Easy to Use• Quick and easy screening test, ready-to-use plates with a

new semi-opaque background

• Clear differentiation of E. faecium and E. faecalis colonies

• Direct inoculation from faecal sample, swab, isolate or suspension

Selective• Inhibition of intrinsically resistant E. casseliflavus and

E. gallinarum, reduces incidence of false-positive results compared to traditional media, minimising confirmatory testing

Reduces Cost• Early presumptive identification of E. faecium and

E. faecalis allows for appropriate treatment and infection control procedures to be adopted earlier, improving treatment outcomes and the effectiveness of infection control measures

Brilliance™ VREDetection of Vancomycin Resistant Enterococci (VRE)

References:1. Bell J.M., Paton J.C., Turnidge J. (1998). Emergence of Vancomycin Resistant

Enterococci in Australia: Phenotypic and Genotypic Characteristic of Isolates. J. Clin. Microbiol. 36, 2187-2190.

2. Centers for Disease Control and Prevention (2006). Recommendations for Preventing the Spread of Vancomycin Resistance: HICPAC.

3. Delmas J., Robin F., Schweitzer C., Lesens O., Bonnet R. (2007). Evaluation of a new chromogenic medium, chromID VRE, for detection of Vancomycin Resistant Enterococci in stool samples and rectal swabs. J. Clin. Microbiol. 45, 2731-2733.

4. Data on file at Oxoid, based on growth or inhibition.

Differentiation of vancomycin resistant E. faecium from E. feacalis is achieved through the inclusion of two chromogens that are targeted by specific enzymes: phosphatase and α-galactosidase. The action of these enzymes on the chromogens results in a build-up of colour within the colony. The colour produced depends on which enzymes the organisms possess. The presence of phosphatase enzymes in both E. faecium and E. feacalis results in a light blue colony, however, E. faecium also produces α-galactosidase, resulting in a mix of blue and pink chromophores within the bacterium producing indigo to purple colonies, which are easily distinguished from the light blue E. feacalis colonies.

Additional antibiotics, in combination with vancomycin, are present to suppress the growth of competing flora including E. gallinarum and E. casseliflavus, both of which are intrinsically resistant to vancomycin, possessing the chromosomally encoded VanC resistance mechanism.

The VanC resistance mechanism is not readily transmissible between organisms and as such is deemed less clinically significant than VanA and VanB mechanisms which are encoded on freely transmissible genetic elements, plasmids and transposons, thus increasing the risk of resistance genes spreading to other organisms.

Page 3: Control the spread of VRE so it doesn’t control you

3

PerformanceVancomycin Resistant Enterococci (VRE) have recently emerged as nosocomial pathogens, due to the increased use of vancomycin for treatment of meticillin-resistant Staphylococcus aureus in the United States of America and use of a vancomycin-like glycopeptide (avoparcin) as a growth promoter in animal husbandry in Europe1.

In the U.S.A., the Centers for Disease Control and Prevention reported that as many as 1 in 3 infections amongst intensive care patients were caused by VRE2. Early detection of VRE is important for infection control and prevention measures, epidemiological infectious disease follow-up, and also prevention of vancomycin resistant Staphylococcus aureus emergence3.

Inoculate Brilliance VRE plate directly with pea sized bead or loopful of specimen.

Negative plates should be re-incubated for an

additional 24 hours

Incubate plates at 37°C for 24hr

Indigo to PurpleE. faecium

Light BlueE. faecalis

Pre-enrich in suitableselective broth prior to

inoculation onto a BrillianceVRE plate. Use an incubationprotocol appropriate to the

broth chosen.

Culti-Loops™

PositiveControlStrain

Enterococcus faecalis (Vancomycin Resistant) ATCC®51299™† CL1996

NegativeControlStrains

Enterococcus faecium ATCC®35667™† CL1956

Enterococcus faecalis ATCC®19433™† CL1990

Enterococcus gallinarum ATCC®700425™† R4601958

Confirmatory Tests

ThermoScientific™RapID™STR 20testpanels R8311003

Rapid identification of streptococci and enterococci

StreptococcusGroupingKit 50tests DR0585A

O.B.I.S.PYR 60tests ID0580M

Antimicrobial Susceptibility Testing M.I.C.Evaluator Strips

M.I.C.Evaluator™StripsFortheaccuratedeterminationoftheminimuminhibitoryconcentration(MIC)ofatestorganismtoanantimicrobial

Vancomycin256-0.016μg/mL 10strips MA0102D

Vancomycin256-0.016μg/mL 50strips MA0102F

Discs

AntimicrobialsusceptibilitytestingdiscsforusewithappropriateASTmediainaccordancewithCLSIM44-A.

Vancomycin5μgDiscs 5x50discs CT0188B

Vancomycin30μgDiscs 5x50discs CT0058B

1282/MS/01/11

Contact Information:International +44(0)1256841144 [email protected]

thermoscientific.com/microbiology

©2013ThermoFisherScientificInc.Allrightsreserved.AlltrademarksarepropertyofThermoFisherScientificInc.,anditssubsidiaries.

Negativeplatesshouldbere-incubatedforanadditional

24 hours

POSITIVE

NEGATIVE

Incubateplatesat37°Cfor24hr

PerformanceVancomycin Resistant Enterococci (VRE) have recently emerged as nosocomial pathogens, due to the increased use of vancomycin for treatmentofmeticillin-resistantStaphylococcus aureusintheUnitedStatesofAmericaanduseofavancomycin-likeglycopeptide(avoparcin)asagrowthpromoterinanimalhusbandryinEurope1.

IntheU.S.A.,theCentersforDiseaseControlandPreventionreportedthatasmanyas1in3infectionsamongstintensivecarepatientswerecausedbyVRE2. Early detection of VRE is important for infection control and preventionmeasures,epidemiologicalinfectiousdiseasefollow-up,andalsoprevention of vancomycin resistant Staphylococcus aureus emergence3.

OxoidBrillianceVREAgarwasevaluatedataclinicaltrialsite,usingapanelof120well-characterised,storedclinicalisolates.Brilliance VRE Agar gave asensitivityof94.7%and100%at24and48hoursrespectively,withthetrialsitereportingthatitwasabletodetectmorepositivesat24hoursthanwiththecompetitorchromogenicagarcurrentlyinuse4.

Inaseparateinternalevaluation,usingapanelof79nonVREstrains,BrillianceVREAgarwas100%selectivecomparedtoacompetitormedia,whichachievedselectivityof94%.

OxoidBrilliance VRE Agar is for in vitrodiagnosticuseonly,bytrainedmicrobiologists.Itmustnotbeusedbeyonditsstatedexpirydate,oriftheproductshowsanysignsofdeterioration.Identificationsarepresumptiveandshouldbeconfirmed.

Screening Procedure

OR

InoculateBrilliance VRE plate directlywithpeasizedbeador

loopful of specimen.

Pre-enrichinsuitableselectivebrothpriorto

inoculation onto a Brilliance VREplate.Useanincubationprotocol appropriate to the

brothchosen.

IndigotoPurple E. faecium

LightBlue E. faecalis

Order Information

Description Packaging Ref

Brilliance VRE Agar 10x90mmplates PO1175A

Other Products in the Brilliance Resistance Screening Range

BrillianceMRSA2Agar(UK) 10x90mmplates PO1210A

BrillianceMRSA2Agar(restofEurope) 10x90mmplates PO5310A

BrillianceESBLAgar 10x90mmplates PO5302A

Oxoid Brilliance Agar Ready-Poured Plates

TheOxoidproductrangeoffersthecompletesolutionforallyourVREscreening and testing needs.

TheATCCLicensedDerivativeEmblem,theATCCLicensedDerivativewordmark,andtheATCCcatalogmarksaretrademarksofATCC.ThermoFisherScientificislicensedtousethesetrademarksandtosellproductsderivedfromATCC®cultures.LookfortheATCCLicensedDerivative®EmblemforproductsderivedfromATCC®cultures.

®

FormoreinformationabouttheThermoScientificBrilliance range of chromogenic media and other products, please visit www.thermoscientific.com/microbiology ortalk to your local representative.

Pleasenote,organismswithanatypicalenzymepatternmaygiveanomalousreactionson Brilliance VRE Agar.

Culti-Loops™

PositiveControlStrain

Enterococcus faecalis (Vancomycin Resistant) ATCC®51299™† CL1996

NegativeControlStrains

Enterococcus faecium ATCC®35667™† CL1956

Enterococcus faecalis ATCC®19433™† CL1990

Enterococcus gallinarum ATCC®700425™† R4601958

Confirmatory Tests

ThermoScientific™RapID™STR 20testpanels R8311003

Rapid identification of streptococci and enterococci

StreptococcusGroupingKit 50tests DR0585A

O.B.I.S.PYR 60tests ID0580M

Antimicrobial Susceptibility Testing M.I.C.Evaluator Strips

M.I.C.Evaluator™StripsFortheaccuratedeterminationoftheminimuminhibitoryconcentration(MIC)ofatestorganismtoanantimicrobial

Vancomycin256-0.016μg/mL 10strips MA0102D

Vancomycin256-0.016μg/mL 50strips MA0102F

Discs

AntimicrobialsusceptibilitytestingdiscsforusewithappropriateASTmediainaccordancewithCLSIM44-A.

Vancomycin5μgDiscs 5x50discs CT0188B

Vancomycin30μgDiscs 5x50discs CT0058B

1282/MS/01/11

Contact Information:International +44(0)1256841144 [email protected]

thermoscientific.com/microbiology

©2013ThermoFisherScientificInc.Allrightsreserved.AlltrademarksarepropertyofThermoFisherScientificInc.,anditssubsidiaries.

Negativeplatesshouldbere-incubatedforanadditional

24 hours

POSITIVE

NEGATIVE

Incubateplatesat37°Cfor24hr

PerformanceVancomycin Resistant Enterococci (VRE) have recently emerged as nosocomial pathogens, due to the increased use of vancomycin for treatmentofmeticillin-resistantStaphylococcus aureusintheUnitedStatesofAmericaanduseofavancomycin-likeglycopeptide(avoparcin)asagrowthpromoterinanimalhusbandryinEurope1.

IntheU.S.A.,theCentersforDiseaseControlandPreventionreportedthatasmanyas1in3infectionsamongstintensivecarepatientswerecausedbyVRE2. Early detection of VRE is important for infection control and preventionmeasures,epidemiologicalinfectiousdiseasefollow-up,andalsoprevention of vancomycin resistant Staphylococcus aureus emergence3.

OxoidBrillianceVREAgarwasevaluatedataclinicaltrialsite,usingapanelof120well-characterised,storedclinicalisolates.Brilliance VRE Agar gave asensitivityof94.7%and100%at24and48hoursrespectively,withthetrialsitereportingthatitwasabletodetectmorepositivesat24hoursthanwiththecompetitorchromogenicagarcurrentlyinuse4.

Inaseparateinternalevaluation,usingapanelof79nonVREstrains,BrillianceVREAgarwas100%selectivecomparedtoacompetitormedia,whichachievedselectivityof94%.

OxoidBrilliance VRE Agar is for in vitrodiagnosticuseonly,bytrainedmicrobiologists.Itmustnotbeusedbeyonditsstatedexpirydate,oriftheproductshowsanysignsofdeterioration.Identificationsarepresumptiveandshouldbeconfirmed.

Screening Procedure

OR

InoculateBrilliance VRE plate directlywithpeasizedbeador

loopful of specimen.

Pre-enrichinsuitableselectivebrothpriorto

inoculation onto a Brilliance VREplate.Useanincubationprotocol appropriate to the

brothchosen.

IndigotoPurple E. faecium

LightBlue E. faecalis

Order Information

Description Packaging Ref

Brilliance VRE Agar 10x90mmplates PO1175A

Other Products in the Brilliance Resistance Screening Range

BrillianceMRSA2Agar(UK) 10x90mmplates PO1210A

BrillianceMRSA2Agar(restofEurope) 10x90mmplates PO5310A

BrillianceESBLAgar 10x90mmplates PO5302A

Oxoid Brilliance Agar Ready-Poured Plates

TheOxoidproductrangeoffersthecompletesolutionforallyourVREscreening and testing needs.

TheATCCLicensedDerivativeEmblem,theATCCLicensedDerivativewordmark,andtheATCCcatalogmarksaretrademarksofATCC.ThermoFisherScientificislicensedtousethesetrademarksandtosellproductsderivedfromATCC®cultures.LookfortheATCCLicensedDerivative®EmblemforproductsderivedfromATCC®cultures.

®

FormoreinformationabouttheThermoScientificBrilliance range of chromogenic media and other products, please visit www.thermoscientific.com/microbiology ortalk to your local representative.

Pleasenote,organismswithanatypicalenzymepatternmaygiveanomalousreactionson Brilliance VRE Agar.

Culti-Loops™

PositiveControlStrain

Enterococcus faecalis (Vancomycin Resistant) ATCC®51299™† CL1996

NegativeControlStrains

Enterococcus faecium ATCC®35667™† CL1956

Enterococcus faecalis ATCC®19433™† CL1990

Enterococcus gallinarum ATCC®700425™† R4601958

Confirmatory Tests

ThermoScientific™RapID™STR 20testpanels R8311003

Rapid identification of streptococci and enterococci

StreptococcusGroupingKit 50tests DR0585A

O.B.I.S.PYR 60tests ID0580M

Antimicrobial Susceptibility Testing M.I.C.Evaluator Strips

M.I.C.Evaluator™StripsFortheaccuratedeterminationoftheminimuminhibitoryconcentration(MIC)ofatestorganismtoanantimicrobial

Vancomycin256-0.016μg/mL 10strips MA0102D

Vancomycin256-0.016μg/mL 50strips MA0102F

Discs

AntimicrobialsusceptibilitytestingdiscsforusewithappropriateASTmediainaccordancewithCLSIM44-A.

Vancomycin5μgDiscs 5x50discs CT0188B

Vancomycin30μgDiscs 5x50discs CT0058B

1282/MS/01/11

Contact Information:International +44(0)1256841144 [email protected]

thermoscientific.com/microbiology

©2013ThermoFisherScientificInc.Allrightsreserved.AlltrademarksarepropertyofThermoFisherScientificInc.,anditssubsidiaries.

Negativeplatesshouldbere-incubatedforanadditional

24 hours

POSITIVE

NEGATIVE

Incubateplatesat37°Cfor24hr

PerformanceVancomycin Resistant Enterococci (VRE) have recently emerged as nosocomial pathogens, due to the increased use of vancomycin for treatmentofmeticillin-resistantStaphylococcus aureusintheUnitedStatesofAmericaanduseofavancomycin-likeglycopeptide(avoparcin)asagrowthpromoterinanimalhusbandryinEurope1.

IntheU.S.A.,theCentersforDiseaseControlandPreventionreportedthatasmanyas1in3infectionsamongstintensivecarepatientswerecausedbyVRE2. Early detection of VRE is important for infection control and preventionmeasures,epidemiologicalinfectiousdiseasefollow-up,andalsoprevention of vancomycin resistant Staphylococcus aureus emergence3.

OxoidBrillianceVREAgarwasevaluatedataclinicaltrialsite,usingapanelof120well-characterised,storedclinicalisolates.Brilliance VRE Agar gave asensitivityof94.7%and100%at24and48hoursrespectively,withthetrialsitereportingthatitwasabletodetectmorepositivesat24hoursthanwiththecompetitorchromogenicagarcurrentlyinuse4.

Inaseparateinternalevaluation,usingapanelof79nonVREstrains,BrillianceVREAgarwas100%selectivecomparedtoacompetitormedia,whichachievedselectivityof94%.

OxoidBrilliance VRE Agar is for in vitrodiagnosticuseonly,bytrainedmicrobiologists.Itmustnotbeusedbeyonditsstatedexpirydate,oriftheproductshowsanysignsofdeterioration.Identificationsarepresumptiveandshouldbeconfirmed.

Screening Procedure

OR

InoculateBrilliance VRE plate directlywithpeasizedbeador

loopful of specimen.

Pre-enrichinsuitableselectivebrothpriorto

inoculation onto a Brilliance VREplate.Useanincubationprotocol appropriate to the

brothchosen.

IndigotoPurple E. faecium

LightBlue E. faecalis

Order Information

Description Packaging Ref

Brilliance VRE Agar 10x90mmplates PO1175A

Other Products in the Brilliance Resistance Screening Range

BrillianceMRSA2Agar(UK) 10x90mmplates PO1210A

BrillianceMRSA2Agar(restofEurope) 10x90mmplates PO5310A

BrillianceESBLAgar 10x90mmplates PO5302A

Oxoid Brilliance Agar Ready-Poured Plates

TheOxoidproductrangeoffersthecompletesolutionforallyourVREscreening and testing needs.

TheATCCLicensedDerivativeEmblem,theATCCLicensedDerivativewordmark,andtheATCCcatalogmarksaretrademarksofATCC.ThermoFisherScientificislicensedtousethesetrademarksandtosellproductsderivedfromATCC®cultures.LookfortheATCCLicensedDerivative®EmblemforproductsderivedfromATCC®cultures.

®

FormoreinformationabouttheThermoScientificBrilliance range of chromogenic media and other products, please visit www.thermoscientific.com/microbiology ortalk to your local representative.

Pleasenote,organismswithanatypicalenzymepatternmaygiveanomalousreactionson Brilliance VRE Agar.

Culti-Loops™

PositiveControlStrain

Enterococcus faecalis (Vancomycin Resistant) ATCC®51299™† CL1996

NegativeControlStrains

Enterococcus faecium ATCC®35667™† CL1956

Enterococcus faecalis ATCC®19433™† CL1990

Enterococcus gallinarum ATCC®700425™† R4601958

Confirmatory Tests

ThermoScientific™RapID™STR 20testpanels R8311003

Rapid identification of streptococci and enterococci

StreptococcusGroupingKit 50tests DR0585A

O.B.I.S.PYR 60tests ID0580M

Antimicrobial Susceptibility Testing M.I.C.Evaluator Strips

M.I.C.Evaluator™StripsFortheaccuratedeterminationoftheminimuminhibitoryconcentration(MIC)ofatestorganismtoanantimicrobial

Vancomycin256-0.016μg/mL 10strips MA0102D

Vancomycin256-0.016μg/mL 50strips MA0102F

Discs

AntimicrobialsusceptibilitytestingdiscsforusewithappropriateASTmediainaccordancewithCLSIM44-A.

Vancomycin5μgDiscs 5x50discs CT0188B

Vancomycin30μgDiscs 5x50discs CT0058B

1282/MS/01/11

Contact Information:International +44(0)1256841144 [email protected]

thermoscientific.com/microbiology

©2013ThermoFisherScientificInc.Allrightsreserved.AlltrademarksarepropertyofThermoFisherScientificInc.,anditssubsidiaries.

Negativeplatesshouldbere-incubatedforanadditional

24 hours

POSITIVE

NEGATIVE

Incubateplatesat37°Cfor24hr

PerformanceVancomycin Resistant Enterococci (VRE) have recently emerged as nosocomial pathogens, due to the increased use of vancomycin for treatmentofmeticillin-resistantStaphylococcus aureusintheUnitedStatesofAmericaanduseofavancomycin-likeglycopeptide(avoparcin)asagrowthpromoterinanimalhusbandryinEurope1.

IntheU.S.A.,theCentersforDiseaseControlandPreventionreportedthatasmanyas1in3infectionsamongstintensivecarepatientswerecausedbyVRE2. Early detection of VRE is important for infection control and preventionmeasures,epidemiologicalinfectiousdiseasefollow-up,andalsoprevention of vancomycin resistant Staphylococcus aureus emergence3.

OxoidBrillianceVREAgarwasevaluatedataclinicaltrialsite,usingapanelof120well-characterised,storedclinicalisolates.Brilliance VRE Agar gave asensitivityof94.7%and100%at24and48hoursrespectively,withthetrialsitereportingthatitwasabletodetectmorepositivesat24hoursthanwiththecompetitorchromogenicagarcurrentlyinuse4.

Inaseparateinternalevaluation,usingapanelof79nonVREstrains,BrillianceVREAgarwas100%selectivecomparedtoacompetitormedia,whichachievedselectivityof94%.

OxoidBrilliance VRE Agar is for in vitrodiagnosticuseonly,bytrainedmicrobiologists.Itmustnotbeusedbeyonditsstatedexpirydate,oriftheproductshowsanysignsofdeterioration.Identificationsarepresumptiveandshouldbeconfirmed.

Screening Procedure

OR

InoculateBrilliance VRE plate directlywithpeasizedbeador

loopful of specimen.

Pre-enrichinsuitableselectivebrothpriorto

inoculation onto a Brilliance VREplate.Useanincubationprotocol appropriate to the

brothchosen.

IndigotoPurple E. faecium

LightBlue E. faecalis

Order Information

Description Packaging Ref

Brilliance VRE Agar 10x90mmplates PO1175A

Other Products in the Brilliance Resistance Screening Range

BrillianceMRSA2Agar(UK) 10x90mmplates PO1210A

BrillianceMRSA2Agar(restofEurope) 10x90mmplates PO5310A

BrillianceESBLAgar 10x90mmplates PO5302A

Oxoid Brilliance Agar Ready-Poured Plates

TheOxoidproductrangeoffersthecompletesolutionforallyourVREscreening and testing needs.

TheATCCLicensedDerivativeEmblem,theATCCLicensedDerivativewordmark,andtheATCCcatalogmarksaretrademarksofATCC.ThermoFisherScientificislicensedtousethesetrademarksandtosellproductsderivedfromATCC®cultures.LookfortheATCCLicensedDerivative®EmblemforproductsderivedfromATCC®cultures.

®

FormoreinformationabouttheThermoScientificBrilliance range of chromogenic media and other products, please visit www.thermoscientific.com/microbiology ortalk to your local representative.

Pleasenote,organismswithanatypicalenzymepatternmaygiveanomalousreactionson Brilliance VRE Agar.

Culti-Loops™

PositiveControlStrain

Enterococcus faecalis (Vancomycin Resistant) ATCC®51299™† CL1996

NegativeControlStrains

Enterococcus faecium ATCC®35667™† CL1956

Enterococcus faecalis ATCC®19433™† CL1990

Enterococcus gallinarum ATCC®700425™† R4601958

Confirmatory Tests

ThermoScientific™RapID™STR 20testpanels R8311003

Rapid identification of streptococci and enterococci

StreptococcusGroupingKit 50tests DR0585A

O.B.I.S.PYR 60tests ID0580M

Antimicrobial Susceptibility Testing M.I.C.Evaluator Strips

M.I.C.Evaluator™StripsFortheaccuratedeterminationoftheminimuminhibitoryconcentration(MIC)ofatestorganismtoanantimicrobial

Vancomycin256-0.016μg/mL 10strips MA0102D

Vancomycin256-0.016μg/mL 50strips MA0102F

Discs

AntimicrobialsusceptibilitytestingdiscsforusewithappropriateASTmediainaccordancewithCLSIM44-A.

Vancomycin5μgDiscs 5x50discs CT0188B

Vancomycin30μgDiscs 5x50discs CT0058B

1282/MS/01/11

Contact Information:International +44(0)1256841144 [email protected]

thermoscientific.com/microbiology

©2013ThermoFisherScientificInc.Allrightsreserved.AlltrademarksarepropertyofThermoFisherScientificInc.,anditssubsidiaries.

Negativeplatesshouldbere-incubatedforanadditional

24 hours

POSITIVE

NEGATIVE

Incubateplatesat37°Cfor24hr

PerformanceVancomycin Resistant Enterococci (VRE) have recently emerged as nosocomial pathogens, due to the increased use of vancomycin for treatmentofmeticillin-resistantStaphylococcus aureusintheUnitedStatesofAmericaanduseofavancomycin-likeglycopeptide(avoparcin)asagrowthpromoterinanimalhusbandryinEurope1.

IntheU.S.A.,theCentersforDiseaseControlandPreventionreportedthatasmanyas1in3infectionsamongstintensivecarepatientswerecausedbyVRE2. Early detection of VRE is important for infection control and preventionmeasures,epidemiologicalinfectiousdiseasefollow-up,andalsoprevention of vancomycin resistant Staphylococcus aureus emergence3.

OxoidBrillianceVREAgarwasevaluatedataclinicaltrialsite,usingapanelof120well-characterised,storedclinicalisolates.Brilliance VRE Agar gave asensitivityof94.7%and100%at24and48hoursrespectively,withthetrialsitereportingthatitwasabletodetectmorepositivesat24hoursthanwiththecompetitorchromogenicagarcurrentlyinuse4.

Inaseparateinternalevaluation,usingapanelof79nonVREstrains,BrillianceVREAgarwas100%selectivecomparedtoacompetitormedia,whichachievedselectivityof94%.

OxoidBrilliance VRE Agar is for in vitrodiagnosticuseonly,bytrainedmicrobiologists.Itmustnotbeusedbeyonditsstatedexpirydate,oriftheproductshowsanysignsofdeterioration.Identificationsarepresumptiveandshouldbeconfirmed.

Screening Procedure

OR

InoculateBrilliance VRE plate directlywithpeasizedbeador

loopful of specimen.

Pre-enrichinsuitableselectivebrothpriorto

inoculation onto a Brilliance VREplate.Useanincubationprotocol appropriate to the

brothchosen.

IndigotoPurple E. faecium

LightBlue E. faecalis

Order Information

Description Packaging Ref

Brilliance VRE Agar 10x90mmplates PO1175A

Other Products in the Brilliance Resistance Screening Range

BrillianceMRSA2Agar(UK) 10x90mmplates PO1210A

BrillianceMRSA2Agar(restofEurope) 10x90mmplates PO5310A

BrillianceESBLAgar 10x90mmplates PO5302A

Oxoid Brilliance Agar Ready-Poured Plates

TheOxoidproductrangeoffersthecompletesolutionforallyourVREscreening and testing needs.

TheATCCLicensedDerivativeEmblem,theATCCLicensedDerivativewordmark,andtheATCCcatalogmarksaretrademarksofATCC.ThermoFisherScientificislicensedtousethesetrademarksandtosellproductsderivedfromATCC®cultures.LookfortheATCCLicensedDerivative®EmblemforproductsderivedfromATCC®cultures.

®

FormoreinformationabouttheThermoScientificBrilliance range of chromogenic media and other products, please visit www.thermoscientific.com/microbiology ortalk to your local representative.

Pleasenote,organismswithanatypicalenzymepatternmaygiveanomalousreactionson Brilliance VRE Agar.

Oxoid Brilliance VRE Agar was evaluated at a clinical trial site, using a panel of 120 well-characterised, stored clinical isolates. Brilliance VRE Agar gave a sensitivity of 94.7% and 100% at 24 and 48 hours respectively, with the trial site reporting that it was able to detect more positives at 24 hours than with the competitor chromogenic agar currently in use4.

In a separate internal evaluation, using a panel of 79 non VRE strains, Brilliance VRE Agar was 100% selective compared to a competitor media, which achieved selectivity of 94%.

Oxoid Brilliance VRE Agar is for in vitro diagnostic use only, by trained microbiologists. It must not be used beyond its stated expiry date, or if the product shows any signs of deterioration. Identifications are presumptive and should be confirmed.

Screening Procedure

or

POSITIVE

NEGATIVE

Please note, organisms with an atypical enzyme pattern may give anomalous reactions on Brilliance VRE Agar.

Page 4: Control the spread of VRE so it doesn’t control you

For more information about the Thermo Scientific Brilliance range of chromogenic media and other products, please visit thermoscientific.com/microbiology or talk to your local representative© 2021 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. LT2651A May 2021

Contact Information:International +44 (0) 1256 841144 [email protected]

The ATCC Licensed Derivative Emblem, the ATCC Licensed Derivative word mark and the ATCC catalog marks are trademarks of ATCC. Remel Inc. is licensed to use these trademarks and to sell products derived from ATCC® cultures. The identity, purity, and authenticity of the Licensed Products are exclusively the responsibility of Remel Inc., and not ATCC.

Order information

Description Packaging Ref

Brilliance VRE Agar 10x90mm plates PO1175AOther products in the Brilliance Resistance Screening range

Brilliance MRSA 2 Agar (UK) 10x90mm plates PO1210ABrilliance MRSA 2 Agar (rest of Europe) 10x90mm plates PO5310ABrilliance ESBL Agar 10x90mm plates PO5302ABrilliance CRE Agar 10x90mm plates PO1226A

The Thermo Scientific product range offers the complete solution for all your VRE screening and testing needs.Culti-Loops™

Positive Control Strain:

Enterococcus faecalis (Vancomycin Resistant) ATCC® 51299™† R4601996Negative Control Strains:

Enterococcus faecium ATCC® 35667™† R4601956Enterococcus faecalis ATCC® 19433™† R4601990Enterococcus gallinarum ATCC® 700425™† R4601958Enterococcus casseliflavus ATCC® 25788™† R4609289Enterococcus faecalis ATCC® 29212™† R4607030

Escherichia coli ATCC® 25922™† R4607050Confirmatory Tests

Thermo Scientific™ RapID™ STR 20 test panels R8311003Rapid identification of streptococci and enterococci

Streptococcus Grouping Kit 50 tests DR0585AO.B.I.S. PYR 60 tests ID0580MDiscsAntimicrobial susceptibility testing discs for use with appropriate AST media in accordance with CLSI M44-A.

Vancomycin 5 μg Discs 5x50 discs CT0188BVancomycin 30 μg Discs 5x50 discs CT0058B

Oxoid Brilliance Agar Ready-Poured Plates